0001209191-15-060930.txt : 20150715
0001209191-15-060930.hdr.sgml : 20150715
20150715170211
ACCESSION NUMBER: 0001209191-15-060930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150713
FILED AS OF DATE: 20150715
DATE AS OF CHANGE: 20150715
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crowley John F
CENTRAL INDEX KEY: 0001400973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 15989784
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-13
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001400973
Crowley John F
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
1
1
0
0
Chairman & CEO
Common Stock
2015-07-13
4
M
0
7750
15.0084
A
91249
D
Common Stock
2015-07-13
4
S
0
7750
15.0084
D
83499
D
Common Stock
2015-07-14
4
M
0
142250
15.0276
A
225749
D
Common Stock
2015-07-14
4
S
0
142250
15.0276
D
83499
D
Common Stock
64895
I
By Trust
Stock Options (right to buy)
4.16
2015-07-13
4
M
0
7750
0.00
D
2013-11-01
2019-11-16
Common Stock
7750
142250
D
Stock Options (right to buy)
4.16
2015-07-14
4
M
0
142250
0.00
D
2013-11-01
2019-11-16
Common Stock
142250
0
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.06. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.06. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.10. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.10. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The stock options exercised under this Rule 10b5-1 trading plan were due to expire on November 16, 2019. After this transaction, Mr. Crowley holds stock options for approximately 2 million shares of Amicus Therapeutics, Inc. common stock.
/s/ John F. Crowley
2015-07-15